in a multicenter prospective randomized trial , the efficacy and toxicity of low-dose ( 400 mg/d ) and high-dose ( 800 mg/d ) oral ketoconazole were compared in 80 patients with blastomycosis and in 54 with histoplasmosis .
C0022625
ketoconazole
C0019655
histoplasmosis